Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 76334

CYP2D6 polymorphism in patients with head and neck cancer


Štefanovic, Mario; Begonja, Antonija; Topić, Elizabeta; Čurčić, Ivica; Šimundić, Ana-Maria
CYP2D6 polymorphism in patients with head and neck cancer // 7th Alps-Adria Congress, Abstracts / Congress Secretariat (ur.).
Regensburg: Congress Secretariat, 2002. (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 76334 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
CYP2D6 polymorphism in patients with head and neck cancer

Autori
Štefanovic, Mario ; Begonja, Antonija ; Topić, Elizabeta ; Čurčić, Ivica ; Šimundić, Ana-Maria

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
7th Alps-Adria Congress, Abstracts / Congress Secretariat - Regensburg : Congress Secretariat, 2002

Skup
7th Alps-Adria Congress International Congress for Clinical Chemistry and Laboratory Medicine

Mjesto i datum
Regensburg, Njemačka, 20.04.2002. - 22.04.2002

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
CYP2D6; head and neck cancer

Sažetak
We investigated the association of drug metabolizing enzyme system CYP P450 CYP2D6 null alleles (CYP2D6*3, *4, *5, *6, *7, and *8) with incidence of tumors in patients having head and neck cancer (HNC). It is known that persons bearing two null alleles poorly metabolize some common drugs (Poor Metabolizer phenotype – PM) as well as other xenobiotic and carcinogenic substances. Persons with only one disrupted CYP2D6 gene (bearing one normal and one null allele) are considered to be Intermediate Metabolizer phenotype (IM). We genotyped 145 controls, and 67 HNC patients by Multiplex Allele Specific PCR on whole blood DNA. Study results showed allelic frequencies for *3, *4 and *6 alleles (only alleles observed) in controls to be 1.4%, 11.0% and 1.0%, respectively; among them we found 2.1% PMs and 22.8% IMs. In cancer patient’s group allelic frequencies for *3, *4 and *6 were 1.5%, 19.4% and 3,7% respectively, and no other alleles were found; among them we found 3.0% PMs and 43.3% IMs. Our study results showed statistically significant difference for genotype frequencies (Chi-square; p=0.025) as well as predicted phenotype frequencies (Chi-square; p=0.034). IM phenotype showed to be responsible for increased risk to HNC (Odds ratio 2.6; 95%CI= 1.248 - 5.193). To confirm our preliminary findings, we plan to study larger group of patients.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
134003

Ustanove:
KBC "Sestre Milosrdnice"


Citiraj ovu publikaciju:

Štefanovic, Mario; Begonja, Antonija; Topić, Elizabeta; Čurčić, Ivica; Šimundić, Ana-Maria
CYP2D6 polymorphism in patients with head and neck cancer // 7th Alps-Adria Congress, Abstracts / Congress Secretariat (ur.).
Regensburg: Congress Secretariat, 2002. (poster, međunarodna recenzija, sažetak, znanstveni)
Štefanovic, M., Begonja, A., Topić, E., Čurčić, I. & Šimundić, A. (2002) CYP2D6 polymorphism in patients with head and neck cancer. U: Congress Secretariat (ur.)7th Alps-Adria Congress, Abstracts.
@article{article, author = {\v{S}tefanovic, Mario and Begonja, Antonija and Topi\'{c}, Elizabeta and \v{C}ur\v{c}i\'{c}, Ivica and \v{S}imundi\'{c}, Ana-Maria}, year = {2002}, pages = {90}, keywords = {CYP2D6, head and neck cancer}, title = {CYP2D6 polymorphism in patients with head and neck cancer}, keyword = {CYP2D6, head and neck cancer}, publisher = {Congress Secretariat}, publisherplace = {Regensburg, Njema\v{c}ka} }
@article{article, author = {\v{S}tefanovic, Mario and Begonja, Antonija and Topi\'{c}, Elizabeta and \v{C}ur\v{c}i\'{c}, Ivica and \v{S}imundi\'{c}, Ana-Maria}, year = {2002}, pages = {90}, keywords = {CYP2D6, head and neck cancer}, title = {CYP2D6 polymorphism in patients with head and neck cancer}, keyword = {CYP2D6, head and neck cancer}, publisher = {Congress Secretariat}, publisherplace = {Regensburg, Njema\v{c}ka} }




Contrast
Increase Font
Decrease Font
Dyslexic Font